Tofacitinib shows promise in scleroderma patients, researchers optimistic for next…
Systemic sclerosis -- or scleroderma that affects the skin and internal organs -, is one of the rarest autoimmune diseases, affecting roughly 100,000 people (primarily women) in the United…